This anti-TNFRSF18 (Ragifilimab Biosimilar) antibody is a Humanized Chimeric antibody detecting TNFRSF18 (Ragifilimab Biosimilar) in . Suitable for Human.
Catalog No. ABIN7597934
Quick Overview for Recombinant TNFRSF18 (Ragifilimab Biosimilar) antibody (ABIN7597934)
Target
TNFRSF18 (Ragifilimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This TNFRSF18 (Ragifilimab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Ragifilimab Biosimilar Antibody
Specificity
Activation-inducible TNFR family receptor, GITR, TNFRSF18, CD357, Tumor necrosis factor receptor superfamily member 18, AITR, Glucocorticoid-induced TNFR-related protein
Purification
Protein A or G purified from cell culture supernatant.
Reactivity: Human
FACS, BLI, ELISA, Func, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
2 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
TNFRSF18 (Ragifilimab Biosimilar)
Alternative Name
Ragifilimab Biosimilar
Target Type
Biosimilar
Background
Activation-inducible TNFR family receptor, GITR, TNFRSF18, CD357, Tumor necrosis factor receptor superfamily member 18, AITR, Glucocorticoid-induced TNFR-related protein